Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

63 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Ki67 (MIB-1) as a Prognostic Marker for Clinical Decision Making Before Extended Pleurectomy Decortication in Malignant Pleural Mesothelioma.
Belderbos RA, Maat APWM, Baart SJ, Madsen EVE, Bogers AJJC, Cornelissen R, Aerts JGJV, Mahtab EAF, von der Thüsen JH. Belderbos RA, et al. Among authors: madsen eve. JTO Clin Res Rep. 2021 Feb 15;2(4):100155. doi: 10.1016/j.jtocrr.2021.100155. eCollection 2021 Apr. JTO Clin Res Rep. 2021. PMID: 34590009 Free PMC article.
Adjuvant dendritic cell based immunotherapy (DCBI) after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal mesothelioma, a phase II single centre open-label clinical trial: rationale and design of the MESOPEC trial.
de Boer NL, van Kooten JP, Burger JWA, Verhoef C, Aerts JGJV, Madsen EVE. de Boer NL, et al. Among authors: madsen eve. BMJ Open. 2019 May 14;9(5):e026779. doi: 10.1136/bmjopen-2018-026779. BMJ Open. 2019. PMID: 31092657 Free PMC article.
Intraperitoneal paclitaxel for patients with primary malignant peritoneal mesothelioma: a phase I/II dose escalation and safety study-INTERACT MESO.
van Kooten JP, Dietz MV, Guchelaar NAD, Brandt-Kerkhof ARM, Koolen SLW, Burger JWA, Mathijssen RHJ, Verhoef C, Aerts JGJV, Madsen EVE. van Kooten JP, et al. Among authors: madsen eve. BMJ Open. 2022 Jun 22;12(6):e062907. doi: 10.1136/bmjopen-2022-062907. BMJ Open. 2022. PMID: 35732399 Free PMC article. Clinical Trial.
Impact of centralization of care for malignant peritoneal mesothelioma: A historical cohort study from the Dutch mesothelioma expert centers.
van Kooten JP, de Gooijer CJ, von der Thüsen JH, Brandt-Kerkhof ARM, Albers AGJ, Lahaye MJ, Monkhorst K, Burgers JA, Aerts JGJV, Verhoef C, Madsen EVE. van Kooten JP, et al. Among authors: madsen eve. Eur J Surg Oncol. 2023 Mar;49(3):611-618. doi: 10.1016/j.ejso.2022.10.003. Epub 2022 Oct 27. Eur J Surg Oncol. 2023. PMID: 36610896 Free article. Review.
Adjuvant dendritic cell-based immunotherapy after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with malignant peritoneal mesothelioma: a phase II clinical trial.
Dietz MV, Quintelier KLA, van Kooten JP, de Boer NL, Vink M, Brandt-Kerkhof ARM, Verhoef C, Saeys Y, Aerts JGJV, Willemsen M, Van Gassen S, Madsen EVE. Dietz MV, et al. Among authors: madsen eve. J Immunother Cancer. 2023 Aug;11(8):e007070. doi: 10.1136/jitc-2023-007070. J Immunother Cancer. 2023. PMID: 37536940 Free PMC article. Clinical Trial.
63 results